Bukirwa H et al: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev 2014;(3):CD006404.
Dondorp AM et al: Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): An open-label, randomised trial. Lancet 2010;376:1647.
Efferth T, Kaina B: Toxicity of the antimalarial artemisinin and its derivatives. Crit Rev Toxicol 2010;40:405.
German PI, Aweeka FT: Clinical pharmacology of artemisinin-based combination therapies. Clin Pharmacokinet 2008;47:91.
Hill DR et al: Primaquine: Report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 2006;75:402.
John GK et al: Primaquine radical cure of Plasmodium vivax: A critical review of the literature. Malar J 2012;11:280.
McGready R et al: Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: A population-based study. Lancet Infect Dis 2012;12:388.
Morris CA et al: Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malar J 2011;10:263.
Nadjm B, Behrens RH: Malaria: An update for physicians. Infect Dis Clin North Am 2012;26:243.
Nosten F et al: Antimalarial drugs in pregnancy: A review. Curr Drug Saf 2006;1:1.
Rehman K, et al: Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence. Int J Infect Dis 2014;29:268.
Rosenthal PJ: Artesunate for the treatment of severe falciparum malaria. N Engl J Med 2008;358:1829.
Rosenthal PJ: The interplay between drug resistance and fitness in malaria parasites. Mol Microbiol 2013;89:1025.
Stepniewska K, White NJ: Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrob Agents Chemother 2008;52:1589.
Taylor WR, White NJ: Antimalarial drug toxicity: A review. Drug Saf 2004; 27:25.
Tilley L et al: Artemisinin Action and Resistance in Plasmodium falciparum. Trends Parasitol 2016 32:682.
White NJ: Cardiotoxicity of antimalarial drugs. Lancet Infect Dis 2007;7:549.
White NJ et al: Malaria. Lancet 2014;383:723.
Whitty CJ, Chiodini PL, Lalloo DG: Investigation and treatment of imported malaria in non-endemic countries. BMJ 2013;346:f2900.
World Health Organization: Guidelines for the treatment of malaria. Geneva. 2015. www.who.int/malaria/publications/atoz/9789241549127/en/.
Fox LM, Saravolatz LD: Nitazoxanide: A new thiazolide antiparasitic agent. Clin Infect Dis 2005;40:1173.